Skip to main content

Main menu

  • About
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Strategic Plan
    • News and Stories
    • Careers
  • Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health
      • Healthy Aging and Mobility
      • Heart Health
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
      • Other Research Focus Areas
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Dilawri Cardiovascular Institute
      • Djavad Mowafaghian Centre for Brain Health
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
    • Research Cores
      • Clinical Trials Platform
      • VCH-VCHRI AI Hub
      • Indigenous Health Research Unit
    • Researcher Directory
    • Events and Workshops
    • Participate in Research
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
    • Research Development
      • Internal Awards
      • Research Facilitation
      • Grant Management
      • Learning and Development
    • Clinical Trials Administration
      • Contract Facilitation
      • Operational Approval
      • Research Privacy
      • Clinical Trials Resources
    • Research Support
      • Communications and Media Relations
      • Financial Policies and Procedures
      • VCH-VCHRI AI Hub
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Clinical Trials
    • Clinical Trials Platform
      • Phase 1 Clinical Trials Research Unit
      • Hematology Research Unit
      • Clinical Research Unit
    • Find a Study
    • Researcher Directory
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home

Optimizing drug treatment for chronic myelogenous leukemia

A phase 3b multicenter, open-label, treatment optimization study of oral asciminib in patients with Chronic Myelogenous Leukemia in Chronic phase (CML-CP) previously treated with 2 or more tyrosine kinase inhibitors
  • Learn more

Genetic testing to prevent and treat male breast cancer

Male Breast Cancer Access Plan to the Hereditary Cancer Program
  • Learn more

Testing the Brain Health PRO support program

The Canadian Therapeutic Platform Trial for Multidomain Interventions to Prevent Dementia (CAN-THUMBS UP or CTU): Brain Health Support Program Intervention (BHSP)
  • Learn more

Evaluating drug efficacy to prevent bacterial sexually transmitted infections

A Randomized Trial of Doxycycline Chemoprophylaxis for the Prevention of Sexually Transmitted Infections in Gay, Bisexual and Other Men Who Have Sex with Men (gbMSM)
  • Learn more

Developing an adaptive fashion guide for people with spinal cord injury

FashionABLE: Adaptive Fashion Guide for the People, by the People with Spinal Cord Injury
  • Learn more

Comparing treatment for atrial fibrillation in the emergency department

RAFF4 Trial: Vernakalant vs. Procainamide for Acute Atrial Fibrillation in the Emergency Department
  • Learn more

Neurocardiac predictors of treatment response to rTMS in depression

Neuro-cardiac Predictors of Treatment Response to rTMS in Depression: A Mechanistic Study Using Interleaved TMS-fMRI
  • Learn more

AI cell analytics app could supercharge biotechnology research

Submitted by vivian.sum@vch.ca on September 20, 2022 - 12:00am

Vancouver, BC – Transformative technology developed by Vancouver Coastal Health Research Institute (VCHRI) researcher Dr. Mads Daugaard at the Vancouver Prostate Centre (VPC) is putting cell analytics into the hands of scientists around the globe. The artificial intelligence (AI)-driven smartphone app SnapCyte produces data used in cell growth medical research at a fraction of the cost and in a more timely manner than current technology.

  • Learn more
3 minutes

Blood type matters for kidney patient priority

Submitted by vivian.sum@vch.ca on September 15, 2022 - 12:49pm

There are currently over 550 patients in British Columbia on a waitlist for a kidney transplant. New research led by Vancouver Coastal Health Research Institute researcher Dr.

  • Learn more
4 minutes

Preventing heart attack and stroke in patients with kidney disease

Submitted by vivian.sum@vch.ca on September 4, 2022 - 8:00am

Statins can prevent heart conditions among patients with chronic kidney disease who have not started dialysis or received a kidney transplant. Yet, new research from Vancouver Coastal Health Research Institute researcher Dr. Hilary Wu indicated that these patients were often not receiving this potentially life-saving medication.

  • Learn more
3 minutes

Pagination

  • Previous page
  • …
  • Page 40
  • Page 41
  • Current page 42
  • Page 43
  • Page 44
  • …
  • Next page
Subscribe to

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • Instagram
  • Bluesky
  • YouTube

© 2026 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy